Form 4 Filing for Esperion Therapeutics, Inc.

This Form 4 filing details a transaction by Sheldon L. Koenig, President and CEO of Esperion Therapeutics, Inc. On June 17, 2026, Koenig sold 53,588 shares of Common Stock at a price of $3.155 per share. This sale was conducted to satisfy tax obligations arising from vested restricted stock units. Following this transaction, Koenig holds 2,119,111 shares of Esperion Therapeutics, Inc. Common Stock. The filing is made in accordance with Section 16 of the Securities Exchange Act of 1934.